# Diannei DNA

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/diannei-dna

- Industry: Healthcare IT
- Headquarters: Shanghai, China
- Website: www.dianneidna.com
- Latest round: Series A (Sep 10, 2021)
- Investors on record: 3

## About

Established in 2016, based in Shanghai, China, Diannei DNA is a biotechnology company which specialties in precision medicine and provide solutions to the user by combining big data and genetic research. The company's core technical team comes from the Sigma Xi Society and the core management team comes from world's top 10 healthcare companies. In September 2021, the company completed series A funding from Qiandao Investment Fund Management and Empower Investment.

The company's product Feianhao is an expert online consultation platform, it provides dozens of expert doctors including radiologist, thoracic surgeons, respiratory experts for users to conduct consultation for lung disease cases. It has the functions of nodules segmentation, nodules positioning, benign and malignant determination, classification of invasiveness and nodules detection.

The products and solutions have been developed for different scenarios such as screening, clinical and new drug development in lung cancer field. involving early screening of lung cancer, begin and malignant determination,preoperative planning and postoperative follow-up, companion diagnostics of targeted drugs and immunodrugs, and evaluation of therapeutic effect of new drug research and development clinical trials.

In the future, the company will strive to build Al solution for the management of cancer, helping doctors and patients improve the efficiency and quality of diagnosis and treatment.

## Funding rounds

- Series A, Sep 10, 2021 — Empower Investment, Qiandao Investment Fund Management
- Angel, Aug 16, 2017 — NNFE

## Investors

- NNFE (https://capitalatlas.ai/funds/nnfe) — Angel
- Empower Investment (https://capitalatlas.ai/funds/empower-investment) — Series A
- Qiandao Investment Fund Management (https://capitalatlas.ai/funds/qiandao-investment-fund-management) — Series A